Condition: Hemoglobinopathy (Disorder) · Severe Aplastic Anemia · Bone Marrow Failure Syndrome · Sponsor: Johns Hopkins All Children's Hospital
This research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient's underlying condition. This study will use stem cells obtained via peripheral blood or bone marrow from parent or other half-matched family member donor. These will be processed through a special device called CliniMACS, which is considered investigational.
This description comes directly from the study's public registry record.
Jade Hanson, MSN · 7277676468 · jade.hanson@jhmi.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins All Children's Hospital | St. Petersburg, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04356469